| Avtor/Urednik | Čufer, T; Vrdoljak, E | |
| Naslov | Sign: a Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer | |
| Tip | članek | |
| Vir | Lung Cancer | |
| Vol. in št. | Letnik 49, št. Suppl 2 | |
| Leto izdaje | 2005 | |
| Obseg | str. S87 | |
| Jezik | eng |